Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

MediPoint: Percutaneous Coronary Interventions Industry Key Trends, Size, Growth, Shares And Forecast Research Report

(PharmaNewsWire.Com, January 13, 2017 ) Coronary stents, which include bare metal stents, drug-eluting stents (DESes), covered stents, and bioabsorbable stents (BASes)

De novo stenosis, acute myocardial infarction (AMI), bifurcation lesions, small vessel disease (SVD), saphenous vein grafts (SVGs), left main coronary artery disease (LMCAD), and chronic total occlusions (CTOs)

In the US and 5EU, coronary stents market value is expected to decline slowly, whereas it is expected to demonstrate steady growth in the APAC and South American regions

Newer technologies, such as BASes and the third generation of DESes aim to address unmet needs of complex lesions and challenging populations

The development and commercialization of the next generation of DESes with innovative platforms indicates the continued value of DESes in the coronary market

The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Medtronic, and Boston Scientific

Other key players include B. Braun, Biosensors International, Biotronik, and Terumo as they develop innovative coronary stent platforms.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=903167

Highlights

Key Questions Answered
- What is the current and future percutaneous coronary interventions market outlook in the developed and emerging markets? What trends are affecting the global market?
- Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with the current generation of devices? How will emerging technologies such as bioabsorbable stents and drug-eluting stents fulfill these unmet needs?
- What is the physician perception of these new technologies? Which indications have been treated most successfully using minimally invasive treatments?
- What are the challenges and complications that have hindered widespread adoption?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global percutaneous coronary interventions market?

Key Findings

- Growth in the percutaneous coronary interventions market will be driven primarily by rising procedure volumes, the increasing global prevalence of coronary artery disease, and as rising rates of diabetes in particular.
- The introduction of Bioabsorbable stents (BASes) can reduce or even eliminate the prolonged use of DAPT; as long-term clinical efficacy data become available, clinicians will prefer to use BASes over drug-eluting stents (DESes).
- Bioabsorbable stents (BASes) are also expected to see fast adoption as they are introduced across major markets, as they have the potential to significantly reduce restenosis rates and allow for vessel remodeling.
- The current key players will need to retain and acquire market share by improving the clinical performance of their existing products.

Scope

- Overview of percutaneous coronary interventions, including reimbursement trends and M&A analysis
- Annualized total market revenue by type of device, procedure trends, and market outlooks by country through 2022.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
- Pipeline analysis: Comprehensive data split across different stages of development and analysis of emerging trends in design.
- Analysis of the current and future market competition in the global percutaneous coronary interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global percutaneous coronary interventions market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global percutaneous coronary interventions market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific peripheral vascular interventions market from 2012-2022.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=903167

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

Follow us on LinkedIn @ http://bit.ly/1TBmnVG

Researchmoz Global Pvt.Ltd

Researchmoz

+1-518-621-2074

sales@researchmoz.us

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC